Karyopharm Therapeutics (KPTI) EBITDA Margin Growth (3y) (2015 - 2025)
Karyopharm Therapeutics (KPTI) EBITDA Margin Growth (3y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Karyopharm Therapeutics |
95.31 Mn |
31.56 Mn |
32.74 Mn |
19,389.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
19,389.00 |
| Sep 30, 2025 |
5,076.00 |
| Jun 30, 2025 |
4,384.00 |
| Mar 31, 2025 |
-3,824.00 |
| Dec 31, 2024 |
-13,961.00 |
| Sep 30, 2024 |
4,848.00 |
| Jun 30, 2024 |
15,129.00 |
| Mar 31, 2024 |
12,325.00 |
| Dec 31, 2023 |
-643.00 |
| Sep 30, 2023 |
13,402.00 |
| Jun 30, 2023 |
4,161.00 |
| Mar 31, 2023 |
18,124.00 |
| Dec 31, 2022 |
13,823.00 |
| Sep 30, 2022 |
21,433.00 |
| Jun 30, 2022 |
33,099.00 |
| Mar 31, 2022 |
4.18 Mn |
| Dec 31, 2021 |
2.79 Mn |
| Sep 30, 2021 |
2.05 Mn |
| Jun 30, 2021 |
-4,442.00 |
| Mar 31, 2021 |
16,426.00 |
